Showing results (41-50 of 261) with videos related to

Sort By:
Pageof 27
Annals of Hematology|October 18, 2023
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphomaReid W Merryman, Robert A Redd, Arnold S Freedman, et al.
Blood|April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantationPhilippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Transplantation and Cellular Therapy|October 20, 2021
Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with LymphomaReid W Merryman, Robert Redd, Erin Jeter, et al.
Hemasphere|January 30, 2023
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W Merryman, Laure Michaud, Robert Redd, et al.
Blood Advances|April 3, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemiaJames T Yoon, Yinglu Zhou, Mariia Mikhaleva, et al.
Leukemia|July 1, 2020
A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignanciesPhilippe Armand, Alexander Lesokhin, Ivan Borrello, et al.
Blood Advances|March 3, 2022
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapySushanth Gouni, Allison C Rosenthal, Jennifer L Crombie, et al.
Cancers|April 30, 2021
The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-AnalysisJisun Hwang, Chong Hyun Suh, Kyung Won Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 9, 2012
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplantsDavid W Kubiak, Sophia Koo, Sarah P Hammond, et al.
Cancer|April 4, 2017
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remissionZachariah DeFilipp, Shuli Li, Areej El-Jawahri, et al.
Pageof 27